Esophageal Cancer
Cancer of the esophagus is rare and among the most complex to treat. That’s why you need a thoracic cancer team that has special expertise in esophageal cancer.At the John Theurer Cancer Center, our thoracic surgeons are the most experienced in the region in treating this disease. You have access to innovative treatments and clinical trials of promising new treatments for esophageal cancer you won’t find anywhere else in the area.
What is Cancer of the Esophagus?
Part of your upper digestive tract, the esophagus is a hollow tube that carries food and liquid from your mouth down your throat to your stomach.
Cancer of the esophagus is usually one of three types:
- Adenocarcinoma: Forms in gland cells that produce mucus in the esophagus. Most often associated with Barrett’s esophagus, GERD (gastroesophageal reflux disease) or obesity that can cause chronic inflammation of the lower esophagus. It is the most common form.
- Small Cell Carcinoma: This rare form of esophageal cancer begins in the neuroendocrine cells that release hormones.
- Squamous Cell Carcinoma: Forms in the thin cells lining the esophagus. Most often associated with smoking and alcohol consumption.
Why Choose John Theurer Cancer Center for Esophageal Cancer Treatment?
Nationally Recognized
- U.S. News & World Report has recognized John Theurer Cancer Center at Hackensack University Medical Center as a premier cancer center in New Jersey.
- Our thoracic surgeons earned a “High Performing” hospital rating for Hackensack University Medical Center by U.S. News & World Report.
Clinical Trials and Research
- You have access to clinical trials that offer hope if your esophageal cancer returns, spreads, is unable to be surgically removed, or does not respond to standard treatments.
- John Theurer Cancer Center conducts hundreds of clinical trials and is the top enroller of patients in Phase 1 clinical trials in New Jersey. Our Research Programs
- As part of the Georgetown Lombardi Comprehensive Cancer Center — a National Cancer Institute-designated comprehensive cancer center —our team offers some of the nation’s most promising Phase I, II and III clinical trials. Find a Clinical Trial
